EUCTR2017-002345-29-FI进行中（未招募）1 期
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigen (PSMA) in prostate cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •-Age: 40 to 85 years old
- •-Language spoken: Finnish
- •-Diagnosis: Histologically confirmed adenocarcinoma of prostate
- •-Adequate histological sampling consisting of at least 3 biopsy samples from each lobe
- •-No previous surgical, radiation or endocrine treatment for prostate carcinoma
- •-Clinical stage:
- •- T1c-T4N0-2M0-1 (Study APhase 1)
- •-Serum creatinine = 1,5 x ULN
- •-Mental status: Patients must be able to understand the meaning of the study
- •-Informed consent: The patient must sign the appropriate Ethical Committee (EC) approved informed consent documents in the presence of the designated staff
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 2
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 3
排除标准
- •-Infections: Patient must not have an uncontrolled serious infection
- •-Contraindications for MRI (cardiac pacemaker, intracranial clips etc)
- •-Prior usage of 5-ARI medication in past 12 months
- •-Patient preference for active surveillance as a method of prostate cancer management
研究者
相似试验
进行中（未招募）
1 期
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigeMedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10071119 Term: Hormone-dependent prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Metastatic prostate cancerEUCTR2018-004853-26-FITurku University Hospital35
招募中
不适用
To determine whether androgen deprivation therapy or androgen blockage therapy upregulates receptor activity of Gallium68 Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) scans for men with castrate resistant prostate cancer.Metastatic Prostate CancerACTRN12617001116314St Vincent's Hospital, Sydney20
招募中
不适用
Effect of androgen deprivation therapy on uptake of PSMA ligand in patients with salivary duct carcinoma: an explorative study.NL-OMON48488Radboud Universitair Medisch Centrum14
尚未招募
3 期
Effect of systematic lifestyle advice & use of cholesterol reducing drugs on cardiovascular disease outcomes among men with newly diagnosed prostate cancer on androgen deprivation therapy.CTRI/2023/07/054807Dr Jehonathan Pinthus Dr Leong Darryl
进行中（未招募）
4 期
The effect of intermittent versus continuous androgen deprivation therapy in Chinese patients with advanced prostate cancer: A prospective controlled Trial from ChinaCancer - Prostateprostate cancerACTRN12613000107729Changhai Hospital, Second Military Medical University100